Nurix Therapeutics, Inc. NRIX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s operating cash flow?
- Nurix Therapeutics, Inc. (NRIX) reported operating cash flow of -$71.91M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s operating cash flow changed year-over-year?
- Nurix Therapeutics, Inc.'s operating cash flow decreased by 17.7% year-over-year, from -$61.09M to -$71.91M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating cash flow?
- Over 3 years (2021 to 2025), Nurix Therapeutics, Inc.'s operating cash flow has grown at a 43.5% compound annual growth rate (CAGR), from -$84.37M to -$249.47M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.